Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

US Patent 11136369 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variable lymphocyte receptors that target the blood brain barrier and methods of2025
Methods, devices and systems for enhanced transduction efficiency2025
Von Willebrand factor proteins for treating bleeding disorders2024
Variable lymphocyte receptors that target the brain extracellular matrix and met2024
Genetically engineered drug resistant T cells and methods of using the same2024
Methods and compositions related to soluble monoclonal variable lymphocyte recep2024
Methods and compositions related to soluble monoclonal variable lymphocyte recep2024
Factor VIII proteins having ancestral sequences, expression vectors, and uses re2024
Factor VIII proteins having ancestral sequences, expression vectors, and uses re2024
Nucleic acids encoding clotting factor variants and their use2023
Cas9 nucleic acid molecules and their use2023
Cas9 nucleic acid molecules and their use2023